Patent details
91544 Product Name: "Alpha alglucosidase"
Basic Information
- Publication number:
- 91544
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP999651623
- Legal Status:
- Lapsed
- Application number:
- 91544
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/06/333/001-003 -Myozyme -Alpha alglucosidase
- Marketing Authorization Type:
- Marketing Authorization Date:
- 29/03/2006
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 25/03/2009
- First Marketing Authorization date:
- 29/03/2006
- Grant date:
- 25/05/2009
- Activation date:
- 06/12/2019
- Publication date:
- 25/05/2009
- Lapsed date:
- 06/12/2019
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 29/03/2021
- SPC Extension Expiration:
- 29/03/2021
- Rejection date:
- Withdrawal date:
Owner
- From:
- 25/03/2009
- Name:
- Genzyme Corporation
- Address:
- 500 Kendall Street, Cambridge, MA 02142, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 25/03/2009
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- MEEKER David, P.
- Address:
- United States (US)
2
- Name:
- VAN BREE Johannes, Brenardus, Mathias, Marie
- Address:
- Netherlands (NL)
3
- Name:
- VENNEKER Edna, Henriette, Germaine
- Address:
- Netherlands (NL)
Publication
Bulletin
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2020/01
- Publication date:
- 13/01/2020
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|